معرفی
Qi Wu is a Research Fellow in the Department of Health Sciences at the University of York, where she has been working since 2010. She holds an MSc in Health Economics and a BSc in Biology with a focus on human diseases. Her expertise centers on economic evaluation alongside clinical trials and the applications of decision-analytic modeling in healthcare.
Her research interests include:
- Economic evaluation alongside clinical trials
- Applications of statistical and decision-analytic methods in cost-effectiveness analysis
- Cost of Illness studies
- Systematic reviews and meta-analyses
- Smoking cessation interventions
- Mental health economic evaluations
Recent publications (2024-2025) show Qi Wu's expanding research portfolio, which continues her longstanding focus on smoking cessation and mental health while branching into dog-assisted interventions for mental health conditions. Her work demonstrates consistent application of health economics methodologies across diverse clinical areas, with a particular emphasis on cost-effectiveness analyses of interventions targeting vulnerable populations including those with mental health conditions.
Notable scientific contributions include:
- Multiple publications on smoking cessation interventions for people with mental illness (ESCAPE project)
- Economic evaluations of various surgical interventions (DISC trial)
- Research on co-located smoking cessation services within lung cancer screening programs (YESS study)
- Methodological contributions to trial reporting standards
Qi Wu has been involved in numerous significant research projects including PHIRST, DISC, SCEPTRE, OPAL2, RAPSODI, YESS, and ESCAPE, primarily focusing on economic evaluations across diverse diseases and conditions. Her work with the UK Centre for Tobacco and Alcohol Studies has been particularly influential in the field of smoking cessation research, especially regarding populations with mental health conditions.
She is an active member of the Trials and Statistics research group within the Department of Health Sciences, contributing to both the design and economic evaluation components of clinical trials.
